Arexvy lyophilized antigen and adjuvant suspension for injection Images
Generic Name: rsv vaccine pref3, recombinant
This medication has been identified as Arexvy lyophilized antigen and adjuvant suspension for injection. It is supplied by GlaxoSmithKline.
Arexvy is used in the treatment of RSV Vaccination and Immunization; RSV and belongs to the drug class viral vaccines. Arexvy lyophilized antigen and adjuvant suspension for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Arexvy
- Generic Name
- rsv vaccine pref3, recombinant
- Strength
- lyophilized antigen and adjuvant suspension for injection
- Availability
- Prescription only
- Drug Class
- Viral vaccines
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 58160-0848
More about Arexvy (rsv vaccine pref3, recombinant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- En español
Patient resources
- Arexvy drug information
- Arexvy (Respiratory syncytial virus vaccine, adjuvanted Intramuscular) (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
